Cancer Research Targets  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhong, H.
Right arrow Articles by Semenza, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhong, H.
Right arrow Articles by Semenza, G. L.
[Cancer Research 60, 1541-1545, March 15, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Modulation of Hypoxia-inducible Factor 1{alpha} Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics1

Hua Zhong, Kelly Chiles, David Feldser, Erik Laughner, Colleen Hanrahan, Maria-Magdalena Georgescu, Jonathan W. Simons2 and Gregg L. Semenza

The Johns Hopkins Oncology Center, Brady Urological Institute [H. Z., C. H., J. W. S.] and Departments of Pediatrics and Medicine and Institute of Genetic Medicine [K. C., D. F., E. L., G. L. S.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, and Laboratory of Molecular Oncology, The Rockefeller University, New York, New York 10021 [M-M. G.]

Dysregulated signal transduction from receptor tyrosine kinases to phosphatidylinositol 3-kinase (PI3K), AKT (protein kinase B), and its effector FKBP-rapamycin-associated protein (FRAP) occurs via autocrine stimulation or inactivation of the tumor suppressor PTEN in many cancers. Here we demonstrate that in human prostate cancer cells, basal-, growth factor-, and mitogen-induced expression of hypoxia-inducible factor 1 (HIF-1) {alpha}, the regulated subunit of the transcription factor HIF-1, is blocked by LY294002 and rapamycin, inhibitors of PI3K and FRAP, respectively. HIF-1-dependent gene transcription is blocked by dominant-negative AKT or PI3K and by wild-type PTEN, whereas transcription is stimulated by constitutively active AKT or dominant-negative PTEN. LY294002 and rapamycin also inhibit growth factor- and mitogen-induced secretion of vascular endothelial growth factor, the product of a known HIF-1 target gene, thus linking the PI3K/PTEN/AKT/FRAP pathway, HIF-1, and tumor angiogenesis. These data indicate that pharmacological agents that target PI3K, AKT, or FRAP in tumor cells inhibit HIF-1{alpha} expression and that such inhibition may contribute to therapeutic efficacy.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. B. Shackelford, D. S. Vasquez, J. Corbeil, S. Wu, M. Leblanc, C.-L. Wu, D. R. Vera, and R. J. Shaw
mTOR and HIF-1{alpha}-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
PNAS, July 7, 2009; 106(27): 11137 - 11142.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Moses, M. A. Ali, S. Zuohe, L. Du-Cuny, L. L. Zhou, R. Lemos, N. Ihle, A. G. Skillman, S. Zhang, E. A. Mash, et al.
In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKT
Cancer Res., June 15, 2009; 69(12): 5073 - 5081.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Thangasamy, J. Rogge, and S. Ammanamanchi
Recepteur d'Origine Nantais Tyrosine Kinase Is a Direct Target of Hypoxia-inducible Factor-1{alpha}-mediated Invasion of Breast Carcinoma Cells
J. Biol. Chem., May 22, 2009; 284(21): 14001 - 14010.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. K. Lau, Z. F. Yang, D. W. Ho, M. N. Ng, G. C.T. Yeoh, R. T.P. Poon, and S. T. Fan
An Akt/Hypoxia-Inducible Factor-1{alpha}/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
Clin. Cancer Res., May 15, 2009; 15(10): 3462 - 3471.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Burkitt, S. Y. Chun, D. T. Dang, and L. H. Dang
Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment
Mol. Cancer Ther., May 1, 2009; 8(5): 1148 - 1156.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-Y. Chang, M.-R. Shen, M.-Y. Lee, W.-L. Wang, W.-C. Su, W.-C. Chang, and B.-K. Chen
Epidermal Growth Factor-activated Aryl Hydrocarbon Receptor Nuclear Translocator/HIF-1{beta} Signal Pathway Up-regulates Cyclooxygenase-2 Gene Expression Associated with Squamous Cell Carcinoma
J. Biol. Chem., April 10, 2009; 284(15): 9908 - 9916.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
G. L. Semenza
Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
Physiology, April 1, 2009; 24(2): 97 - 106.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Lu, K. Zhang, S. Chen, and W. Wen
Grape seed extract inhibits VEGF expression via reducing HIF-1{alpha} protein expression
Carcinogenesis, April 1, 2009; 30(4): 636 - 644.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Scortegagna, R. J. Martin, R. D. Kladney, R. G. Neumann, and J. M. Arbeit
Hypoxia-Inducible Factor-1{alpha} Suppresses Squamous Carcinogenic Progression and Epithelial-Mesenchymal Transition
Cancer Res., March 15, 2009; 69(6): 2638 - 2646.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Harada, S. Itasaka, S. Kizaka-Kondoh, K. Shibuya, A. Morinibu, K. Shinomiya, and M. Hiraoka
The Akt/mTOR Pathway Assures the Synthesis of HIF-1{alpha} Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors
J. Biol. Chem., February 20, 2009; 284(8): 5332 - 5342.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Cai, J. Wang, R. Li, G. Ayala, M. Ittmann, and M. Liu
GGAP2/PIKE-A Directly Activates Both the Akt and Nuclear Factor-{kappa}B Pathways and Promotes Prostate Cancer Progression
Cancer Res., February 1, 2009; 69(3): 819 - 827.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Vasseur, S. Afzal, J. Tardivel-Lacombe, D. S. Park, J. L. Iovanna, and T. W. Mak
DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses
PNAS, January 27, 2009; 106(4): 1111 - 1116.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. X. Knaup, K. Jozefowski, R. Schmidt, W. M. Bernhardt, A. Weidemann, J. S. Juergensen, C. Warnecke, K.-U. Eckardt, and M. S. Wiesener
Mutual Regulation of Hypoxia-Inducible Factor and Mammalian Target of Rapamycin as a Function of Oxygen Availability
Mol. Cancer Res., January 1, 2009; 7(1): 88 - 98.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. M. Greenberger, I. D. Horak, D. Filpula, P. Sapra, M. Westergaard, H. F. Frydenlund, C. Albaek, H. Schroder, and H. Orum
A RNA antagonist of hypoxia-inducible factor-1{alpha}, EZN-2968, inhibits tumor cell growth
Mol. Cancer Ther., November 1, 2008; 7(11): 3598 - 3608.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Ader, L. Brizuela, P. Bouquerel, B. Malavaud, and O. Cuvillier
Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1{alpha} during Hypoxia in Human Cancer Cells
Cancer Res., October 15, 2008; 68(20): 8635 - 8642.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z.-B. Han, H. Ren, H. Zhao, Y. Chi, K. Chen, B. Zhou, Y.-j. Liu, L. Zhang, B. Xu, B. Liu, et al.
Hypoxia-inducible factor (HIF)-1{alpha} directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)
Carcinogenesis, October 1, 2008; 29(10): 1853 - 1861.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Mahadevan, G. Powis, E. A. Mash, B. George, V. M. Gokhale, S. Zhang, K. Shakalya, L. Du-Cuny, M. Berggren, M. A. Ali, et al.
Discovery of a novel class of AKT pleckstrin homology domain inhibitors
Mol. Cancer Ther., September 1, 2008; 7(9): 2621 - 2632.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Gallo, G. F. Zannoni, I. De Stefano, M. Mosca, C. Ferlini, E. Mantuano, and G. Scambia
Soy Phytochemicals Decrease Nonsmall Cell Lung Cancer Growth In Female Athymic Mice
J. Nutr., July 1, 2008; 138(7): 1360 - 1364.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Plathow and W. A. Weber
Tumor Cell Metabolism Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
X. Li, Y. Lu, K. Liang, T. Pan, J. Mendelsohn, and Z. Fan
Requirement of hypoxia-inducible factor-1{alpha} down-regulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab
Mol. Cancer Ther., May 1, 2008; 7(5): 1207 - 1217.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. A. Fritz, T.-M. Lin, and R. E. Peterson
The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates
Carcinogenesis, May 1, 2008; 29(5): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. P. Deudero, C. Caramelo, M. C. Castellanos, F. Neria, R. Fernandez-Sanchez, O. Calabia, S. Penate, and F. R. Gonzalez-Pacheco
Induction of Hypoxia-inducible Factor 1{alpha} Gene Expression by Vascular Endothelial Growth Factor
J. Biol. Chem., April 25, 2008; 283(17): 11435 - 11444.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Scortegagna, C. Cataisson, R. J. Martin, D. J. Hicklin, R. D. Schreiber, S. H. Yuspa, and J. M. Arbeit
HIF-1{alpha} regulates epithelial inflammation by cell autonomous NF{kappa}B activation and paracrine stromal remodeling
Blood, April 1, 2008; 111(7): 3343 - 3354.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. M. Emerling, F. Weinberg, J.-L. Liu, T. W. Mak, and N. S. Chandel
PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a)
PNAS, February 19, 2008; 105(7): 2622 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Furuta, S. K. Pai, R. Zhan, S. Bandyopadhyay, M. Watabe, Y.-Y. Mo, S. Hirota, S. Hosobe, T. Tsukada, K. Miura, et al.
Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1
Cancer Res., February 15, 2008; 68(4): 1003 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. A. Carroll and M. Ashcroft
Regulation of Angiogenic Factors by HDM2 in Renal Cell Carcinoma
Cancer Res., January 15, 2008; 68(2): 545 - 552.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. R. Garlich, P. De, N. Dey, J. D. Su, X. Peng, A. Miller, R. Murali, Y. Lu, G. B. Mills, V. Kundra, et al.
A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity
Cancer Res., January 1, 2008; 68(1): 206 - 215.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Y. Koh, T. Spivak-Kroizman, S. Venturini, S. Welsh, R. R. Williams, D. L. Kirkpatrick, and G. Powis
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1{alpha}
Mol. Cancer Ther., January 1, 2008; 7(1): 90 - 100.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. L. Lee, W. H. Kim, J. Jung, S. J. Cho, J.-W. Park, J. Kim, H.-Y. Chung, M. S. Chang, and S. Y. Nam
A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer
Carcinogenesis, January 1, 2008; 29(1): 44 - 51.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
A. Rapisarda and G. Melillo
HIF-1 Inhibitors: Novel Opportunities for Cancer Therapy
ASCO Educational Book, January 1, 2008; 2008(1): 543 - 547.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Klatte, D. B. Seligson, S. B. Riggs, J. T. Leppert, M. K. Berkman, M. D. Kleid, H. Yu, F. F. Kabbinavar, A. J. Pantuck, and A. S. Belldegrun
Hypoxia-Inducible Factor 1{alpha} in Clear Cell Renal Cell Carcinoma
Clin. Cancer Res., December 15, 2007; 13(24): 7388 - 7393.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. J. Anand, S. C. Gribar, J. Li, J. W. Kohler, M. F. Branca, T. Dubowski, C. P. Sodhi, and D. J. Hackam
Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1{alpha}-dependent manner
J. Leukoc. Biol., November 1, 2007; 82(5): 1257 - 1265.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Nasimuzzaman, G. Waris, D. Mikolon, D. G. Stupack, and A. Siddiqui
Hepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1{alpha} and Stimulates the Synthesis of Vascular Endothelial Growth Factor
J. Virol., October 1, 2007; 81(19): 10249 - 10257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. W. J. Young, O. W. Williams, D. Chandra, L. K. Bellinghausen, G. Perez, A. Suarez, M. J. Tuvim, M. G. Roy, S. N. Alexander, S. J. Moghaddam, et al.
Central Role of Muc5ac Expression in Mucous Metaplasia and Its Regulation by Conserved 5' Elements
Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 273 - 290.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Milkiewicz, J. L. Doyle, T. Fudalewski, E. Ispanovic, M. Aghasi, and T. L. Haas
HIF-1{alpha} and HIF-2{alpha} play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle
J. Physiol., September 1, 2007; 583(2): 753 - 766.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Q. Zhang, X. Tang, Z.-F. Zhang, R. Velikina, S. Shi, and A. D. Le
Nicotine Induces Hypoxia-Inducible Factor-1{alpha} Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor Mediated Signaling Pathways
Clin. Cancer Res., August 15, 2007; 13(16): 4686 - 4694.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Ma, C. Hu, A. T. Riegel, S. Fan, and E. M. Rosen
Growth Factor Signaling Pathways Modulate BRCA1 Repression of Estrogen Receptor-{alpha} Activity
Mol. Endocrinol., August 1, 2007; 21(8): 1905 - 1923.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M.-C. Lauzier, E. L. Page, M. D. Michaud, and D. E. Richard
Differential Regulation of Hypoxia-Inducible Factor-1 through Receptor Tyrosine Kinase Transactivation in Vascular Smooth Muscle Cells
Endocrinology, August 1, 2007; 148(8): 4023 - 4031.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Flugel, A. Gorlach, C. Michiels, and T. Kietzmann
Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1{alpha} and Mediates Its Destabilization in a VHL-Independent Manner
Mol. Cell. Biol., May 1, 2007; 27(9): 3253 - 3265.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. A. Kazi and R. D. Koos
Estrogen-Induced Activation of Hypoxia-Inducible Factor-1{alpha}, Vascular Endothelial Growth Factor Expression, and Edema in the Uterus Are Mediated by the Phosphatidylinositol 3-Kinase/Akt Pathway
Endocrinology, May 1, 2007; 148(5): 2363 - 2374.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Tang, Q. Zhang, J. Nishitani, J. Brown, S. Shi, and A. D. Le
Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Hypoxia-Inducible Factor 1{alpha} Protein Accumulation and Vascular Endothelial Growth Factor Expression in Human Cervical Carcinoma Cells
Clin. Cancer Res., May 1, 2007; 13(9): 2568 - 2576.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. J. Lum, T. Bui, M. Gruber, J. D. Gordan, R. J. DeBerardinis, K. L. Covello, M. C. Simon, and C. B. Thompson
The transcription factor HIF-1{alpha} plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis
Genes & Dev., May 1, 2007; 21(9): 1037 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. T. Kurmasheva, F. C. Harwood, and P. J. Houghton
Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors
Mol. Cancer Ther., May 1, 2007; 6(5): 1620 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Murata and M. Moriyama
Isoleucine, an Essential Amino Acid, Prevents Liver Metastases of Colon Cancer by Antiangiogenesis
Cancer Res., April 1, 2007; 67(7): 3263 - 3268.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Fang, Q. Zhou, L.-Z. Liu, C. Xia, X. Hu, X. Shi, and B.-H. Jiang
Apigenin inhibits tumor angiogenesis through decreasing HIF-1{alpha} and VEGF expression
Carcinogenesis, April 1, 2007; 28(4): 858 - 864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Wang, S. S. Li, R. Segersvard, L. Strommer, K.-G. Sundqvist, J. Holgersson, and J. Permert
Hypoxia Inducible Factor-1 Mediates Effects of Insulin on Pancreatic Cancer Cells and Disturbs Host Energy Homeostasis
Am. J. Pathol., February 1, 2007; 170(2): 469 - 477.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. G. Kaelin Jr.
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
Clin. Cancer Res., January 15, 2007; 13(2): 680s - 684s.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Q. Zhou, L.-Z. Liu, B. Fu, X. Hu, X. Shi, J. Fang, and B.-H. Jiang
Reactive oxygen species regulate insulin-induced VEGF and HIF-1{alpha} expression through the activation of p70S6K1 in human prostate cancer cells
Carcinogenesis, January 1, 2007; 28(1): 28 - 37.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Ramanathan, G. Pinhal-Enfield, I. Hao, and S. J. Leibovich
Synergistic Up-Regulation of Vascular Endothelial Growth Factor (VEGF) Expression in Macrophages by Adenosine A2A Receptor Agonists and Endotoxin Involves Transcriptional Regulation via the Hypoxia Response Element in the VEGF Promoter
Mol. Biol. Cell, January 1, 2007; 18(1): 14 - 23.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Tanaka, M. Yamamoto, N. Hashimoto, M. Miyakoshi, S. Tamakawa, M. Yoshie, Y. Tokusashi, K. Yokoyama, Y. Yaginuma, and K. Ogawa
Hypoxia-Independent Overexpression of Hypoxia-Inducible Factor 1{alpha} as an Early Change in Mouse Hepatocarcinogenesis
Cancer Res., December 1, 2006; 66(23): 11263 - 11270.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. C. Birle and D. W. Hedley
Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts.
Mol. Cancer Ther., October 1, 2006; 5(10): 2494 - 2502.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Pore, A. K. Gupta, G. J. Cerniglia, Z. Jiang, E. J. Bernhard, S. M. Evans, C. J. Koch, S. M. Hahn, and A. Maity
Nelfinavir Down-regulates Hypoxia-Inducible Factor 1{alpha} and VEGF Expression and Increases Tumor Oxygenation: Implications for Radiotherapy.
Cancer Res., September 15, 2006; 66(18): 9252 - 9259.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Serganova, J. Humm, C. Ling, and R. Blasberg
Tumor hypoxia imaging.
Clin. Cancer Res., September 15, 2006; 12(18): 5260 - 5264.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. T. Jones, C. W. Pugh, S. Wigfield, M. F.G. Stevens, and A. L. Harris
Novel Thioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-{alpha} Expression but Decrease Functional Transcriptional Activity, DNA Binding, and Degradation.
Clin. Cancer Res., September 15, 2006; 12(18): 5384 - 5394.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-H. Peng, P. Karna, Z. Cao, B.-H. Jiang, M. Zhou, and L. Yang
Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1{alpha} Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene Expression
J. Biol. Chem., September 8, 2006; 281(36): 25903 - 25914.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
K S Kimbro and J W Simons
Hypoxia-inducible factor-1 in human breast and prostate cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 739 - 749.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R. P Singh and R. Agarwal
Mechanisms of action of novel agents for prostate cancer chemoprevention.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 751 - 778.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. T. Jones and A. L. Harris
Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding.
Mol. Cancer Ther., September 1, 2006; 5(9): 2193 - 2202.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
G. Melillo
Inhibiting Hypoxia-Inducible Factor 1 for Cancer Therapy
Mol. Cancer Res., September 1, 2006; 4(9): 601 - 605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. H. Haase
Hypoxia-inducible factors in the kidney
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F271 - F281.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C.-C. Chang, M.-T. Lin, B.-R. Lin, Y.-M. Jeng, S.-T. Chen, C.-Y. Chu, R. J. Chen, K.-J. Chang, P.-C. Yang, and M.-L. Kuo
Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
J Natl Cancer Inst, July 19, 2006; 98(14): 984 - 995.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Riss, C. Khanna, S. Koo, G. V.R. Chandramouli, H. H. Yang, Y. Hu, D. E. Kleiner, A. Rosenwald, C. F. Schaefer, S. A. Ben-Sasson, et al.
Cancers as Wounds that Do Not Heal: Differences and Similarities between Renal Regeneration/Repair and Renal Cell Carcinoma.
Cancer Res., July 15, 2006; 66(14): 7216 - 7224.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Freeman, R. Lesche, N. Kertesz, S. Wang, G. Li, J. Gao, M. Groszer, H. Martinez-Diaz, N. Rozengurt, G. Thomas, et al.
Genetic Background Controls Tumor Development in Pten-Deficient Mice.
Cancer Res., July 1, 2006; 66(13): 6492 - 6496.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Pore, Z. Jiang, H.-K. Shu, E. Bernhard, G. D. Kao, and A. Maity
Akt1 Activation Can Augment Hypoxia-Inducible Factor-1{alpha} Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin-Independent Pathway
Mol. Cancer Res., July 1, 2006; 4(7): 471 - 479.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Solban, S. K. Pal, S. K. Alok, C. K. Sung, and T. Hasan
Mechanistic Investigation and Implications of Photodynamic Therapy Induction of Vascular Endothelial Growth Factor in Prostate Cancer
Cancer Res., June 1, 2006; 66(11): 5633 - 5640.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Litz and G. W. Krystal
Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1{alpha} activity and vascular endothelial growth factor expression in small cell lung cancer cells.
Mol. Cancer Ther., June 1, 2006; 5(6): 1415 - 1422.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. A. Garcia
HIFing the Brakes: Therapeutic Opportunities for Treatment of Human Malignancies
Sci. Signal., May 30, 2006; 2006(337): pe25 - pe25.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Q. Zhang, O. W. Moe, J. A. Garcia, and C. C. W. Hsia
Regulated expression of hypoxia-inducible factors during postnatal and postpneumonectomy lung growth
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L880 - L889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Li, Y. Hu, Y. Huo, M. Liu, D. Freeman, J. Gao, X. Liu, D.-C. Wu, and H. Wu
PTEN Deletion Leads to Up-regulation of a Secreted Growth Factor Pleiotrophin
J. Biol. Chem., April 21, 2006; 281(16): 10663 - 10668.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
B. N. Gomperts and R. M. Strieter
CXC Chemokines in Angiogenesis and Metastases
Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 11 - 18.
[Full Text] [PDF]


Home page
BloodHome page
M. Calvani, A. Rapisarda, B. Uranchimeg, R. H. Shoemaker, and G. Melillo
Hypoxic induction of an HIF-1{alpha}-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells
Blood, April 1, 2006; 107(7): 2705 - 2712.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Pore, Z. Jiang, A. Gupta, G. Cerniglia, G. D. Kao, and A. Maity
EGFR Tyrosine Kinase Inhibitors Decrease VEGF Expression by Both Hypoxia-Inducible Factor (HIF)-1-Independent and HIF-1-Dependent Mechanisms.
Cancer Res., March 15, 2006; 66(6): 3197 - 3204.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Kaper, N. Dornhoefer, and A. J. Giaccia
Mutations in the PI3K/PTEN/TSC2 Pathway Contribute to Mammalian Target of Rapamycin Activity and Increased Translation under Hypoxic Conditions
Cancer Res., February 1, 2006; 66(3): 1561 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. T. Dang, F. Chen, L. B. Gardner, J. M. Cummins, C. Rago, F. Bunz, S. V. Kantsevoy, and L. H. Dang
Hypoxia-Inducible Factor-1{alpha} Promotes Nonhypoxia-Mediated Proliferation in Colon Cancer Cells and Xenografts
Cancer Res., February 1, 2006; 66(3): 1684 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Skuli, S. Monferran, C. Delmas, I. Lajoie-Mazenc, G. Favre, C. Toulas, and E. Cohen-Jonathan-Moyal
Activation of RhoB by Hypoxia Controls Hypoxia-Inducible Factor-1{alpha} Stabilization through Glycogen Synthase Kinase-3 in U87 Glioblastoma Cells
Cancer Res., January 1, 2006; 66(1): 482 - 489.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
H. Acker
The oxygen sensing signal cascade under the influence of reactive oxygen species
Phil Trans R Soc B, December 29, 2005; 360(1464): 2201 - 2210.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Dekanty, S. Lavista-Llanos, M. Irisarri, S. Oldham, and P. Wappner
The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-{alpha}/Sima
J. Cell Sci., December 1, 2005; 118(23): 5431 - 5441.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. S. Lee, H. S. Park, S. J. Park, S. R. Kim, K. H. Min, S. M. Jin, K.-H. Park, U.-H. Kim, C. Y. Kim, and Y. C. Lee
A Prodrug of Cysteine, L-2-Oxothiazolidine-4-carboxylic Acid, Regulates Vascular Permeability by Reducing Vascular Endothelial Growth Factor Expression in Asthma
Mol. Pharmacol., November 1, 2005; 68(5): 1281 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
R. H. Wenger, D. P. Stiehl, and G. Camenisch
Integration of Oxygen Signaling at the Consensus HRE
Sci. Signal., October 18, 2005; 2005(306): re12 - re12.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Kong, E. J. Park, A. G. Stephen, M. Calvani, J. H. Cardellina, A. Monks, R. J. Fisher, R. H. Shoemaker, and G. Melillo
Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding Activity
Cancer Res., October 1, 2005; 65(19): 9047 - 9055.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Q. Zhang, X. Tang, Q. Y. Lu, Z. F. Zhang, J. Brown, and A. D. Le
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1{alpha} and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells
Mol. Cancer Ther., October 1, 2005; 4(10): 1465 - 1474.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y.-T. Huang, S.-L. Pan, J.-H. Guh, Y.-L. Chang, F.-Y. Lee, S.-C. Kuo, and C.-M. Teng
YC-1 suppresses constitutive nuclear factor-{kappa}B activation and induces apoptosis in human prostate cancer cells
Mol. Cancer Ther., October 1, 2005; 4(10): 1628 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Maloyan, L. Eli-Berchoer, G. L. Semenza, G. Gerstenblith, M. D. Stern, and M. Horowitz
HIF-1{alpha}-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart
Physiol Genomics, September 21, 2005; 23(1): 79 - 88.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J.-Y. Han, S. H. Oh, F. Morgillo, J. N. Myers, E. Kim, W. K. Hong, and H.-Y. Lee
Hypoxia-inducible Factor 1{alpha} and Antiangiogenic Activity of Farnesyltransferase Inhibitor SCH66336 in Human Aerodigestive Tract Cancer
J Natl Cancer Inst, September 7, 2005; 97(17): 1272 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. Trisciuoglio, A. Iervolino, G. Zupi, and D. Del Bufalo
Involvement of PI3K and MAPK Signaling in bcl-2-induced Vascular Endothelial Growth Factor Expression in Melanoma Cells
Mol. Biol. Cell, September 1, 2005; 16(9): 4153 - 4162.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. A. Adjei and M. Hidalgo
Intracellular Signal Transduction Pathway Proteins As Targets for Cancer Therapy
J. Clin. Oncol., August 10, 2005; 23(23): 5386 - 5403.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. W. Nelson, H. Cao, Y. Zhu, B. Sunar-Reeder, C. Y.H. Choi, J. D. Faix, J. M. Brown, A. C. Koong, A. J. Giaccia, and Q.-T. Le
A Noninvasive Approach for Assessing Tumor Hypoxia in Xenografts: Developing a Urinary Marker for Hypoxia
Cancer Res., July 15, 2005; 65(14): 6151 - 6158.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. Busca, E. Berra, C. Gaggioli, M. Khaled, K. Bille, B. Marchetti, R. Thyss, G. Fitsialos, L. Larribere, C. Bertolotto, et al.
Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells
J. Cell Biol., July 4, 2005; 170(1): 49 - 59.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
T Gaber, R Dziurla, R Tripmacher, G R Burmester, and F Buttgereit
Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!
Ann Rheum Dis, July 1, 2005; 64(7): 971 - 980.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. M. Emerling, L. C. Platanias, E. Black, A. R. Nebreda, R. J. Davis, and N. S. Chandel
Mitochondrial Reactive Oxygen Species Activation of p38 Mitogen-Activated Protein Kinase Is Required for Hypoxia Signaling
Mol. Cell. Biol., June 15, 2005; 25(12): 4853 - 4862.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Xiao, C. Yin, C. Yang, A. Di Cristofano, P. P. Pandolfi, and T. Van Dyke
Somatic Induction of Pten Loss in a Preclinical Astrocytoma Model Reveals Major Roles in Disease Progression and Avenues for Target Discovery and Validation
Cancer Res., June 15, 2005; 65(12): 5172 - 5180.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Nakamura, Y. Makino, K. Okamoto, L. Poellinger, K. Ohnuma, C. Morimoto, and H. Tanaka
TCR Engagement Increases Hypoxia-Inducible Factor-1{alpha} Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells
J. Immunol., June 15, 2005; 174(12): 7592 - 7599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Phillips, J. Mestas, M. Gharaee-Kermani, M. D. Burdick, A. Sica, J. A. Belperio, M. P. Keane, and R. M. Strieter
Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1{alpha}
J. Biol. Chem., June 10, 2005; 280(23): 22473 - 22481.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. W. Cole Jr, A. M. Alleva, R. M. Reddy, J. B. Maxhimer, J. Zuo, D. S. Schrump, and D. M. Nguyen
The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1010 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, M.-N. Monthouel-Kartmann, and E. Van Obberghen
Regulation of Hypoxia-Inducible Factor (HIF)-1 Activity and Expression of HIF Hydroxylases in Response to Insulin-Like Growth Factor I
Mol. Endocrinol., May 1, 2005; 19(5): 1304 - 1317.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Connor, S. Subbaram, K. J. Regan, K. K. Nelson, J. E. Mazurkiewicz, P. J. Bartholomew, A. E. Aplin, Y.-T. Tai, J. Aguirre-Ghiso, S. C. Flores, et al.
Mitochondrial H2O2 Regulates the Angiogenic Phenotype via PTEN Oxidation
J. Biol. Chem., April 29, 2005; 280(17): 16916 - 16924.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. M. Li, B. P. Zhou, J. Deng, Y. Pan, N. Hay, and M.-C. Hung
A Hypoxia-Independent Hypoxia-Inducible Factor-1 Activation Pathway Induced by Phosphatidylinositol-3 Kinase/Akt in HER2 Overexpressing Cells
Cancer Res., April 15, 2005; 65(8): 3257 - 3263.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al.
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.